A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD
Pancreatic Cancer, Common Bile Duct Diseases, Periampullary Carcinoma
About this trial
This is an interventional treatment trial for Pancreatic Cancer focused on measuring Robot pancreaticoduodenectomy, laparoscopic pancreaticoduodenectomy, randomized controlled trial, Safety and Efficacy
Eligibility Criteria
Inclusion Criteria: Over 18 years old Preoperative imaging suggested the presence of space occupying in the head of the pancreas, ampullary abdomen, and distal common bile duct tumor lesions to be treated with Pancreaticoduodenectomy No distant transfer No significant vascular invasion was received Exclusion Criteria: With tumors of other organs Patients unable to tolerate anesthesia and operation due to serious abnormalities in functions of heart, lung and other important organs Patients found intraoperative peripheral organ metastasis combined with excision of other organs or found intraoperative radical excision could not be performed and underwent palliative drainage surgery or end the surgery Preoperative adjuvant therapy was given
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Other
Other
laparoscopic pancreaticoduodenectomy group
Robot Pancreaticoduodenectomy
The laparoscopic group will perform the surgical procedure using laparoscopic instruments, with three surgeons involved throughout the procedure.
The robotic team will perform the surgery using the latest generation Da Vinci robotic surgical system, with an additional surgeon assisting in the procedure.